Lowering cholesterol

Cholesterol damage is a lifetime-exposure disease: modestly lower numbers held for decades beat big corrections started late.

Updated 2026-09-04

Test yourself: Blood pressure quiz7 questions · ~1 minStart →

Cholesterol, by the numbers

🩸
−22%

fewer heart attacks and strokes for every 1 mmol/L (39 mg/dL) of LDL you lower and keep lowered, in 170,000 trial participants [1].

LDL you can take off

Measured LDL reductions from randomized trials

PCSK9 inhibitor−59%
High-intensity statin−50%
Portfolio diet (oats, nuts, soy, sterols)−29%
Swapping saturated for unsaturated fat−10%

[2] · [1] · [3] · [4]

The short version

  • •Plaque is a lifetime-exposure disease: people dealt genetically lower LDL plus lower blood pressure, about 1 mmol/L and 10 mm Hg, have an 86% lower lifetime risk of major cardiovascular events [5]. Your numbers in your 30s and 40s matter most.
  • •The same LDL drop is worth about 3x more when it starts early in life than when treatment starts late [6]. Decades of slightly-lower beats years of much-lower.
  • •Lowering works, however you do it: every 1 mmol/L of LDL reduction cuts major vascular events about 22% and all-cause mortality about 10% across 170,000 trial participants [1].
  • •Food moves real numbers: the portfolio diet (oats, nuts, soy, plant sterols) lowered LDL 28.6% in a randomized trial, statistically indistinguishable from a starting statin dose [3].
  • •Ask for ApoB, the particle count that predicts risk better than LDL, and get Lp(a) measured once in your life: about 1 in 5 people carry a genetic particle no lifestyle change touches.
  • •"Good cholesterol" is mostly a myth: drugs that raise HDL failed to prevent heart attacks in big trials. Spend your effort on lowering ApoB, not raising HDL.
Test yourself: Blood pressure quiz7 questions · ~1 minStart →

Cholesterol is the most misunderstood number in the blood panel. It causes no symptoms, the damage compounds silently for decades, and the public conversation is stuck on eggs and "good versus bad" while the actual science has moved to particle counts and lifetime exposure. The evidence here is unusually strong: cholesterol is one of the few risk factors proven causal by genetics, by randomized trials of several different drug classes, and by diet trials, all pointing the same direction. Here is what matters most, ranked by the strength of the evidence, each with one thing you can actually do.

1

Knowing your number, ideally ApoB

You cannot manage unmeasured risk, and cholesterol gives no warning signs. ApoB, a count of the particles that actually burrow into artery walls, predicts risk better than LDL cholesterol itself: in 389,000 UK Biobank adults it was the strongest single lipid predictor of heart disease [7] [8].

Do this

Get a lipid panel and ask for ApoB with it; the test costs a few dollars more. Under about 80 mg/dL is a good place to be; under 60 is where aggressive-prevention guidelines point. Repeat every few years, not once a decade.

Take the heart health quiz →
2

Starting early, because exposure is cumulative

Plaque grows with LDL multiplied by time, like pack-years for smoking. People with genetic variants giving them 1 mmol/L lower LDL plus 10 mm Hg lower blood pressure for life have an 86% lower lifetime risk of major cardiovascular events [5], and the same LDL drop delivers about 3x more benefit started early than started late [6].

Do this

Do not wait for a milestone birthday. If your LDL or ApoB is high in your 20s, 30s, or 40s, act now through food, exercise, or medication. Modest and early beats dramatic and late.

Take the heart health quiz →
3

Treating high numbers seriously

Statins are among the most-studied drugs in history: across 26 randomized trials and 170,000 people, each 1 mmol/L of LDL lowering cut major vascular events by 22% and death from any cause by 10% [1]. Newer options stack: ezetimibe adds benefit (IMPROVE-IT) [9], and PCSK9 inhibitors cut LDL 59% on top of statins and reduced events further [2].

Do this

If your ApoB or LDL stays high after a real diet effort, or your calculated risk is elevated, have the statin conversation instead of renegotiating with the number every year. Muscle side effects are rarer than reputation suggests: in blinded trials most symptoms appeared equally on placebo.

Take the heart health quiz →
4

Swapping saturated fat for unsaturated, not for sugar

Replacing saturated fat (butter, fatty meat, cream) with unsaturated fat (olive oil, nuts, fish) lowers LDL predictably, about 10% for a realistic swap [4], and a Cochrane review of 56,000 trial participants found cutting saturated fat reduced cardiovascular events 17% [10]. Replacing it with refined carbs delivers no benefit. Dietary cholesterol itself, eggs included, moves blood cholesterol far less than saturated fat does for most people.

Do this

Make the default swaps: olive oil where you used butter, nuts where you snacked on pastry, fish or beans twice a week where red meat was. Ignore the egg panic; watch the butter and processed meat instead.

Take the diet quiz →
5

Soluble fiber and the portfolio effect

Soluble fiber binds cholesterol-rich bile in the gut and sends it out of the body: 3 g a day of oat beta-glucan, one big bowl of oats, lowers LDL about 5 to 7% [11]. Stack the proven foods, oats, nuts, soy protein, beans, plant sterols, and you get the portfolio diet, which cut LDL 28.6% in four weeks in a randomized trial, matching a starting statin dose [3].

Do this

Add one soluble-fiber anchor per day: oats or barley at breakfast, or a cup of beans or lentils at lunch. A handful of nuts most days is the second-easiest portfolio ingredient to adopt.

Take the diet quiz →
6

Weight, especially around the middle

Visceral fat drives the metabolic half of the lipid panel: high triglycerides, low HDL, and smaller, denser LDL particles. Weight loss of 5 to 10% reliably lowers triglycerides by double-digit percentages and modestly lowers LDL (Dattilo and Kris-Etherton [12] meta-analysis), and it improves blood pressure and blood sugar with the same effort.

Do this

If your triglycerides run high and your waist is more than half your height, treat weight, and the sugary drinks and refined carbs behind it, as lipid treatment. Triglycerides respond to carbohydrate cuts faster than LDL responds to anything.

Take the body weight quiz →
7

Exercise, the particle-quality lever

Exercise moves LDL only a little, but it improves the profile around it: in the randomized STRRIDE trial, regular jogging-level exercise raised HDL, lowered triglycerides, and shifted LDL toward larger, less dangerous particles, with amount of exercise mattering more than intensity [13]. Fitness also cuts cardiovascular risk through pathways no lipid number captures.

Do this

Do not run to fix your LDL; run because it fixes the context your LDL operates in. The familiar 150 minutes a week of brisk movement is the evidence-backed dose.

Take the exercise quiz →
8

Lp(a), the once-in-a-lifetime test

Lipoprotein(a) is an LDL-like particle set almost entirely by your genes: about 1 in 5 people have levels high enough to independently raise heart attack and aortic-valve risk (Kronenberg et al. [14] consensus). Diet and exercise barely move it, which is exactly why knowing it matters: a high Lp(a) argues for treating everything else more aggressively.

Do this

Ask for Lp(a) once; European guidelines now recommend every adult measure it one time. If it is high, that is not fatalism, it is a mandate to keep ApoB, blood pressure, and smoking status impeccable.

Take the heart health quiz →
9

Not chasing HDL

HDL predicts risk in observation but raising it does not lower risk: niacin raised HDL 25% and prevented nothing on top of statins [15], CETP-inhibitor drugs raised it over 100% and mostly failed, and Mendelian randomization of genetically high HDL shows no protection [16]. HDL is a marker of metabolic health, not a lever.

Do this

Skip supplements and hacks sold to "boost good cholesterol". The behaviors that genuinely raise HDL, exercise and weight loss, are worth doing for their own sake; the HDL number is just their shadow.

Take the heart health quiz →

How to tell if yours is good

Signals you can read yourself, starting today, and what a good reading looks like.

LDL / ApoB

Tested within 2 years; ApoB under about 80 mg/dL (LDL under about 100)

Lp(a)

Measured once in your life and discussed if high

Triglycerides

Fasting under 150 mg/dL, a proxy for the metabolic side

Fat sources

Olive oil, nuts, and fish are the defaults; butter and processed meat the exceptions

Soluble fiber

Oats, barley, beans, or lentils on most days

If treated

On the plan consistently, with a follow-up panel confirming the target

Check your own risk

6 quick questions about you, not the article. You get a personal readout of where your risks sit.

Pick an answer to reveal the numbers: check points for every answer (+2p working for you, +1p worth tightening, +0p elevated risk), plus life-model years where an answer maps to one (+0y = measured, no effect on its own).

1. Your cholesterol (LDL or ApoB) is…

2. If your cholesterol runs high, are you and a doctor treating or managing it?

3. Your everyday fats are mostly…

4. Oats, barley, beans, or lentils on a typical day?

5. Your fasting triglycerides, if you have seen them, are…

6. Have you ever had Lp(a) measured?

Now score your own

These two-minute quizzes turn this research into your numbers, and the years they are worth.

Go deeper in the Wiki

Sources

  1. [1]Cholesterol Treatment Trialists’ (CTT) Collaboration et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 376(9753):1670-81, 2010. doi:10.1016/S0140-6736(10)61350-5 Evidence: High
  2. [2]M. S. Sabatine et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med, 376(18):1713-1722, 2017. doi:10.1056/NEJMoa1615664 Evidence: Moderate
  3. [3]D. J. Jenkins et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA, 290(4):502-10, 2003. doi:10.1001/jama.290.4.502 Evidence: Low
  4. [4]R. P. Mensink et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr, 77(5):1146-55, 2003. doi:10.1093/ajcn/77.5.1146 Evidence: High
  5. [5]B. A. Ference et al. Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease. JAMA, 322(14):1381-1391, 2019. doi:10.1001/jama.2019.14120 Evidence: Low
  6. [6]B. A. Ference et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol, 60(25):2631-9, 2012. doi:10.1016/j.jacc.2012.09.017 Evidence: High
  7. [7]A. D. Sniderman et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol, 4(12):1287-1295, 2019. doi:10.1001/jamacardio.2019.3780 Evidence: Very low
  8. [8]C. Welsh et al. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease. Circulation, 140(7):542-552, 2019. doi:10.1161/circulationaha.119.041149 Evidence: Low
  9. [9]C. P. Cannon et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med, 372(25):2387-97, 2015. doi:10.1056/NEJMoa1410489 Evidence: Moderate
  10. [10]L. Hooper et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev, 5(5):CD011737, 2020. doi:10.1002/14651858.CD011737.pub2 Evidence: Moderate
  11. [11]A. Whitehead et al. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr, 100(6):1413-21, 2014. doi:10.3945/ajcn.114.086108 Evidence: High
  12. [12]A. M. Dattilo and P. M. Kris-Etherton. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr, 56(2):320-8, 1992. doi:10.1093/ajcn/56.2.320 Evidence: Moderate
  13. [13]W. E. Kraus et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med, 347(19):1483-92, 2002. doi:10.1056/NEJMoa020194 Evidence: Low
  14. [14]F. Kronenberg et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J, 43(39):3925-3946, 2022. doi:10.1093/eurheartj/ehac361 Evidence: Not graded (guideline)
  15. [15]AIM-HIGH Investigators et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med, 365(24):2255-67, 2011. doi:10.1056/NEJMoa1107579 Evidence: Moderate
  16. [16]B. F. Voight et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet, 380(9841):572-80, 2012. doi:10.1016/S0140-6736(12)60312-2 Evidence: Moderate

See where you sit

Email

Longevity posts, plain English

Occasional notes when we publish: what the studies say, without hype. Unsubscribe anytime.

YapSpan estimates are for reflection and entertainment only. They are not medical advice, a diagnosis, or a prediction of any individual outcome. Check with a doctor before making any medical decision.